Abstract ISI
ARTHRITIS AND RHEUMATISM  (2005)

Tumor necrosis factor-alpha-308 G/G promoter polymorphism correlates with a better response to adalimumab in patients with rheumatoid arthritis.

Cuchacovich M.; Soto, L; Edwardes, M; Gutierrez, M; Llanos, C.; Pacheco, D; Sabugo, F; Alamo, M; Fuentealba, C; Villanueva, L; Gatica H.; Schiattino, I; Salazar, L; Catalán, D; Valenzuela, O; et. al.